Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype

American Journal of Pathology

Volumn 159, Issue 1, 2001, Pages 193-203

  Afanasyeva, Marina ^a   Wang, Yan ^a   Kaya, Ziya ^a   Park, Sung ^a   Zilliox, Michael J ^a   Schofield, Brian H ^a   Hill, Susan L ^a,c   Rose, Noel R ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 4; MONOCLONAL ANTIBODY; MYOSIN;

ANIMAL; ARTICLE; AUTOIMMUNE DISEASE; BIOSYNTHESIS; CELL CULTURE; HEART MUSCLE; HOSPITALIZATION; IMMUNOLOGY; METABOLISM; MOUSE; MOUSE STRAIN; MYOCARDITIS; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; SPLEEN; TH2 CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CELLS, CULTURED; CYTOKINES; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-4; MICE; MICE, INBRED STRAINS; MYOCARDITIS; MYOCARDIUM; MYOSINS; PHENOTYPE; SEVERITY OF ILLNESS INDEX; SPLEEN; TH2 CELLS;

EID: 0035403326     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61685-9     Document Type: Article

References (76)

1. Drory Y, Turetz Y, Hiss Y, Lev B, Fisman EZ, Pines A, Kramer MR: Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 1991, 68:1388-1392
2. Brown CA, O'Connell JB: Myocarditis and idiopathic dilated cardiomyopathy. Am J Med 1995, 99:309-314
3. Caforio AL, Goldman JH, Haven AJ, Baig KM, McKenna WJ: Evidence for autoimmunity to myosin and other heart-specific autoantigens n patients with dilated cardiomyopathy and their relatives. Int J Cardiol 1996, 54:157-163
4. Lauer B, Schannwell M, Kuhl U, Strauer BE, Schultheiss HP: Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol 2000, 35:11-18
5. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE: A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995, 333:269-275
6. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW: Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987, 139:3630-3636
7. Lane JR, Neumann DA, Lafond-Walker A, Herskowitz A, Rose NR: Interleukin 1 and tumor necrosis factor can promote coxsackie B3-induced myocarditis in resistant B10.A mice. J Exp Med 1992, 175: 1123-1129
8. Smith SC, Allen PM: Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. Circ Res 1992, 70:856-863
9. Bachmaier K, Pummerer C, Kozieradzki I, Pfeffer K, Mak TW, Neu N, Penninger JM: Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease. Circulation 1997, 95:655-661
10. Liblau RS, Singer SM, McDevitt HO: Th1 and Th2 CD4+ cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995, 16:34-38
11. Mosmann TR, Sad S: The expanding universe of T-cell subsets: th1, Th2, and more. Immunol Today 1996, 17:138-146
12. Boehm U, Klamp T, Groot M, Howard JC: Cellular responses to interferon-γ. Annu Rev Immunol 1997, 15:749-795
13. Finkelman FD, Holmes J, Katona IM, Urban Jr JF, Beckman MP, Park LS, Schooley KS, Coffman RL, Mosmann TR, Paul WE: Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990, 8:303-333
14. 4 integrin. J Immunol 1999, 163:3441-3448
15. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE: The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999, 17:701-738
16. Shiverick KL, Thomas LL, Alpert NR: Purification of cardiac myosin. Application to hypertrophied myocardium. Biochim Biophys Acta 1975, 393:124-133
17. Wang Y, Afanasyeva M, Hill SL, Rose NR: Characterization of murine autoimmune myocarditis induced by self and foreign cardiac myosin. Autoimmunity 1999, 31:151-162
18. Donermeyer DL, Beisel KW, Allen PM, Smith SC: Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart. J Exp Med 1995, 182:1291-1300
19. Pakala SV, Kurrer MO, Katz JD: T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J Exp Med 1997, 186:299-306
20. Kopf M, Le Gros G, Coyle AJ, Kosco-Vilbois M, Brombacher F: Immune responses of IL-4, IL-5, IL-6 deficient mice. Immunol Rev 1995, 148:45-69
21. Nishimura T, Iwakabe K, Sekimoto M, Ohmi Y, Yahata T, Nakui M, Sato T, Habu S, Tashiro H, Sato M, Ohta A: Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo. J Exp Med 1999, 190:617-627
22. McNally AK, Anderson JM: Interleukin-4 induces foreign body giant cells from human monocyte/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am J Pathol 1995, 147:1487-1499
23. McInnes A, Rennick DM: Interleukin-4 induces cultured monocytes/ macrophages to form giant multinucleated cells. J Exp Med 1988, 167:598-611
24. Ando DG, Clayton J, Kono D, Urban JL, Sercarz EE: Encephalito-genic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol 2000, 124:132-143
25. Shaw MK, Lorens JB, Dhawan A, DalCanto R, Tse HY, Tran AB, Bonpane C, Eswaran SL, Brocke S, Sarvetnick N, Steinman L, Nolan GP, Fathman CG: Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J Exp Med 1997, 185:1711-1714
26. Falcone M, Bloom BR: A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J Exp Med 1997, 185:901-907
27. Katz JD, Benoist C, Mathis D: T helper cell subsets in insulin-dependent diabetes. Science 1995, 268:1185-1188
28. Gallichan WS, Balasa B, Davies JD, Sarvetnick N: Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. J Immunol 1999, 163: 1696-1703
29. Boirivant M, Fuss IJ, Chu A, Strober W: Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 1998, 188:1929-1939
30. Jacobs MJ, van den Hoek AE, van Lent PL, van de Loo FA, van de Putte LB, Van Den Berg WB: Role of IL-2 and IL-4 in exacerbations of murine antigen-induced arthritis. Immunology 1994, 83:390-396
31. Ramanathan S, de Kozak Y, Saoudi A, Goureau O, Van der Meide PH, Druet P, Bellon B: Recombinant IL-4 aggravates experimental autoimmune uveoretinitis in rats. J Immunol 1996, 157:2209-2215
32. Caspi RR, Chan C-C, Grubbs BG, Silver PB, Wiggert B, Parsa CF, Bahmanyar S, Billiau A, Heremans H: Endogenous systemic IFN-γ has a protective role against ocular autoimmunity in mice. J Immunol 1994, 152:890-899
33. Hesse M, Bayrak S, Mitchison A: Protective major histocompatibility complex genes and the role of interleukin-4 in collagen-induced arthritis. Eur J Immunol 1996, 26:3234-3237
34. Lafaille JJ, van de Keere F, Hsu AL, Baron JL, Haas W, Raine CS, Tonegawa S: Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J Exp Med 1997, 186:307-312
35. Sarvetnick N, Shizuru J, Liggitt D, Martin L, McIntyre B, Gregory A, Parslow T, Stewart T: Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature 1990, 346:844-847
36. Barret SP, Gleeson PA, de Silva H, Toh BH, van Driel IR: Interferon-γ is required during the initiation of an organ-specific autoimmune disease. Eur J Immunol 1996, 26:1652-1655
37. Tang H, Mignon-Godefroy K, Meroni PL, Garotta G, Charreire J, Nicoletti F: The effects of a monoclonal antibody to interferon-gamma on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT-specific T cells. Eur J Immunol 1993, 23:275-278
38. Lublin FD, Knobler RL, Kalman B, Goldhaber M, Marini J, Perrault M, D'Imperio C, Joseph J, Alkan SS, Korngold R: Monoclonal anti-γ interleron antibodies enhance experimental allergic encephalomyelitis (EAE). Autoimmunity 1993, 16:264-274
39. Vermeire K, Heremans H, Vandeputte M, Huang J, Billiau A, Matthys P: Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice. J Immunol 1997, 158:5507-5513
40. Matthys P, Vermeire K, Heremans H, Billiau A: The protective effect of IFN-gamma in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis. J Leukoc Biol 2000, 68:447-454
41. Iwamoto I, Nakajima H, Endo H, Yoshida S: Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells. J Exp Med 1993, 177: 573-576
42. Gajewski TF, Fitch FW: Anti-proliterative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol 1988, 140:4245-4252
43. Pernis A, Gupta S, Gollob KJ, Garfein E, Coffman RL, Schindler C, Rothman P: Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. Science 1995, 269:245-247
44. Liu Y, Janeway Jr CA: Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance. J Exp Med 1990, 172:1735-1739
45. Albina JE, Abate JA, Henry Jr WL: Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway. J Immunol 1991, 147:144-148
46. Dalton DK, Haynes L, Chu CQ, Swain SL, Wittmer S: Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J Exp Med 2000, 192:117-122
47. Chu CQ, Wittmer S, Dalton DK: Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J Exp Med 2000, 192:123-128
48. Badovinac VP, Tvinnereim AR, Harty JT: Regulation of antigen-specific CD8(+) T cell homeostasis by perforin and interferon-gamma. Science 2000, 290:1354-1358
49. Eriksson U, Kurrer MO, Bingisser R, Eugster HP, Saremaslani P, Follath F, Marsch S, Widmer U: Lethal autoimmune myocarditis in interferon-gamma receptor-deficient mice: enhanced disease severity by impaired inducible nitric oxide synthase induction. Circulation 2001, 103:18-21
50. Matsukura S, Stellato C, Plitt JR, Bickel C, Miura K, Georas SN, Casolaro V, Schleimer RP: Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells. J Immunol 1999, 163:6876-6883
51. Tepper RI, Coffman RL, Leder P: An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 1992, 257:548-551
52. Tepper RI, Pattengale PK, Leder P: Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 1989, 57:503-512
53. Patella V, de Crescenzo G, Marino I, Genovese A, Adt M, Gleich GJ, Marone G: Eosinophil granule proteins are selective activators of human heart mast cells. J Immunol 1996, 157:1219-1225
54. Vitetta ES, Ohara J, Myers CD, Layton JE, Krammer PH, Paul WE: Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1. J Exp Med 1985, 162:726-731
55. Hazenbos WL, Heijnen IA, Meyer D, Hofhuis FM, Renardel de Lavalette CR, Schmidt RE, Capel PJ, van de Winkel JG, Gessner JE, van den Berg TK, Verbeek JS: Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). J Immunol 1998, 161:3026-3032
56. Graziano RF, Looney RJ, Shen L, Fanger MW: Fc gamma R-mediated killing by eosinophils. J Immunol 1989, 142:230-235
57. Weiler CR, Kita H, Hukee M, Gleich GJ: Eosinophil viability during immunoglobulin-induced degranulation. J Leukoc Biol 1996, 60:493-501
58. de Andres B, Rakasz E, Hagen M, McCormik ML, Mueller AL, Elliot D, Metwali A, Sandor M, Britigan BE, Weinstock JV, Lynch RG: Lack of Fc-epsilon receptors on murine eosinophils: implications for the functional significance of elevated IgE and eosinophils in parasitic infections. Blood 1997, 89:3826-3836
59. Liao L, Sindhwani R, Rojkind M, Factor S, Leinwand L, Diamond B: Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J Exp Med 1995, 181:1123-1131
60. Smith SC, Allen PM: Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol 1991, 147:2141-2147
61. De Vries JE: The role of IL-13 and its receptor in allergy and inflammatory responses J Allergy Clin Immunol 1998, 102:165-169
62. McKenzie GJ, Fallon PG, Emson CL, Grencis RK, McKenzie ANJ: Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J Exp Med 1999, 189: 1565-1572
63. Coffman RL, Seymour BW, Hudak S, Jackson J, Rennick D: Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 1989, 245:308-310
64. Wang Y, Afanasyeva M, Hill SL, Kaya Z, Rose NR: Nasal administration of cardiac myosin suppresses autoimmune myocarditis in mice. J Am Coll Cardiol 2000, 36:1992-1999
65. Barks JL, McQuillan JJ, Iademarco MF: TNF-alpha and IL-4 synergistically increase vascular cell adhesion molecule-1 expression in cultured vascular smooth muscle cells. J Immunol 1997, 159:4532-4538
66. Iademarco MF, Barks JL, Dean DC: Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells J Clin Invest 1995, 95:264-271
67. Bjorck P: Development of dendritic cells and their use in tumor therapy. Clin Immunol 1999, 92:119-127
68. Austyn JM, Hankins DF, Larsen CP, Morris PJ, Rao AS, Roake JA: Isolation and characterization of dendritic cells from mouse heart and kidney. J Immunol 1994, 152:2401-2410
69. Shen CH, Stavnezer J: Interaction of state and NF-kappaB: direct association and synergistic activation of interleukin-4-induced transcription. Mol Cell Biol 1998, 18:3395-3404
70. Barnes PJ: Therapeutic strategies for allergic diseases. Nature 1999, 402(Suppl.)B31-B38
71. Caspi RR: IL-12 in autoimmunity. Clin Immunol Immunopathol 1998, 88:4-13
72. Okura Y, Takeda K, Honda S, Hanawa H, Watanabe H, Kodama M, Izumi T, Aizawa Y, Seki S, Abo T: Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats. Circ Res 1998, 82:1035-1042
73. Karp CL, Grupe A, Schadt E. Ewart SL, Keane-Moore M, Cuomo PJ, Kohl J, Wahl L, Kuperman D, Germer S, Aud D, Peltz G, Wills-Karp M: Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nature Immunol 2000, 1:221-226
74. Huber SA: Coxsackievirus-induced myocarditis is dependent on distinct immunopathogemc responses in different strains of mice. Lab Invest 1997, 76:691-701
75. Iizawa Y, Wagner RD, Czuprynski CJ: Analysis of cytokine mRNA expression in Listeria-resistant C57BL/6 and Listeria-susceptible A/J mice during Listeria monocytogenes infection. Infect Immun 1993, 61:3739-3744
76. McCarthy RE, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL: Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000, 342:690-695